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Background: Improvements in health care for children with chronic diseases must be informed by research that
emphasizes outcomes of importance to patients and families. To support a program of research in the field of rare
inborn errors of metabolism (IEM), we conducted a broad scoping review of primary studies that: (i) focused on
chronic pediatric diseases similar to IEM in etiology or manifestations and in complexity of management; (ii) reported
patient- and/or family-oriented outcomes; and (iii) measured these outcomes using self-administered tools.
Methods: We developed a comprehensive review protocol and implemented an electronic search strategy to
identify relevant citations in Medline, EMBASE, DARE and Cochrane. Two reviewers applied pre-specified criteria to
titles/abstracts using a liberal accelerated approach. Articles eligible for full-text review were screened by two
independent reviewers with discrepancies resolved by consensus. One researcher abstracted data on study characteristics,
patient- and family-oriented outcomes, and self-administered measures. Data were validated by a second researcher.
Results: 4,118 citations were screened with 304 articles included. Across all included reports, the most-represented
diseases were diabetes (35%), cerebral palsy (23%) and epilepsy (18%). We identified 43 unique patient- and
family-oriented outcomes from among five emergent domains, with mental health outcomes appearing most
frequently. The studies reported the use of 405 independent self-administered measures of these outcomes.
Conclusions: Patient- and family-oriented research investigating chronic pediatric diseases emphasizes mental
health and appears to be relatively well-developed in the diabetes literature. Future research can build on this
foundation while identifying additional outcomes that are priorities for patients and families.
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Table 1 PICOS for scoping review of patient- and
family-oriented outcomes, measures for children with
chronic diseases
Patients Children and/or adolescents (i.e., 0-18 yrs) with a
chronic disease for which etiology/manifestation(s)
are genetic, metabolic or neurologic, and which
necessitates specialist pediatric care involving
medical, surgical or nutritional intervention, and/or;




Outcome Patient- and family-oriented (as defined by the




Peer-reviewed, English-language, full journal
articles describing primary studies that included
≥5 eligible patients, published 2002-2012
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Rare pediatric diseases pose unique challenges for the
planning and provision of patient-centred health care
[1-3]. These challenges arise from the chronicity and com-
plexity of these diseases, combined with small numbers of
patients available for empirical research to investigate
patient-and family-oriented outcomes [4]. Generating the
evidence to fill these knowledge gaps is challenging [5] as
outcomes for children are often proxy-reported [6], affect
caregivers as well as patients [7,8], and change over time
as adolescents transition from pediatric to adult care [9].
Despite these challenges, incorporating outcomes that
align with the priorities of patients and their families is in-
creasingly recognized as imperative in evaluative health
research [10-13]. This reflects a growing body of literature
supporting patient-centred health care [14,15], and related
concepts including patient-informed care [16], shared
decision-making [17,18], and personalized health care
[19,20]. These trends represent an emerging consensus
that the perspectives of patients and their families are crit-
ical to evaluating health interventions in order to effect-
ively inform improvements in health care [21-23].
As part of a larger program of research designed to ad-
vance health outcomes and interventions for children with
rare inborn errors of metabolism (IEM) [24], we con-
ducted a broad scoping review of patient- and family-
oriented outcomes and self-administered measures of
these outcomes for chronic pediatric diseases with fea-
tures relevant to IEM. Our review addressed the following
questions:
1) Which patient- and family-oriented outcomes have
been measured in studies of chronic pediatric
diseases relevant to IEM?
2) Which self-administered measures have been used
to measure the outcomes identified in 1)?
Methods
Because our questions were broad, we adopted a tailored
scoping review approach which is reported in detail else-
where [25]. Briefly, we established an expert working
group to develop a structured review protocol and exe-
cute the search and synthesis of reports of relevant stud-
ies. The group included those with clinical expertise in
managing IEM, an understanding of patient-reported
outcomes research in pediatrics, and experience with
knowledge synthesis methods. Because there are few
studies describing patient/family-oriented outcomes spe-
cific to patients with IEM [26], we considered a broader
range of diseases with clinical similarities to IEM. Specific-
ally, we identified hallmark characteristics of IEM: (i) eti-
ology and/or manifestation (genetic, metabolic, and/or
neurologic); (ii) chronicity (requiring long-term manage-
ment); (iii) nature/complexity of care (requiring specialistpediatric care involving medical, surgical or nutritional
intervention); and (iv) rarity. We used these characteristics
to define our eligibility criteria with the exception of dis-
ease rarity, as we did not wish to pre-suppose differences
in outcomes relevant to rare versus common diseases, i.e.,
restricting the review to rare diseases would potentially
have been limiting in the context of our objectives.
Eligible outcomes were patient- and/or family-oriented,
defined using the approach developed by the authors of
the Strength of Recommendation Taxonomy Framework
[27], a scale developed for ascertaining the extent to which
evidence is patient-oriented. Eligible outcome measures
were self-administered, to identify those that can be com-
pleted without a researcher being present and therefore of
broadest potential utility. We operationalized these
features, in combination with limitations on report/
study characteristics intended to narrow the search
yield to sources most relevant to our research objec-
tives and questions, as inclusion criteria using the pa-
tient, intervention(s), comparator(s), outcome(s), study
design (PICOS) framework [28] (Table 1).
A search strategy was developed iteratively to identify
relevant studies while yielding a feasible number of cita-
tions. For example, we searched diseases of interest using
Medical Subject Headings (MeSH) only, while we com-
bined text word searches with MeSH to identify relevant
outcomes. Likewise, while both English- and French-
language articles were retrieved with the electronic search
strategy, we reviewed only English-language articles.
The final search strategy for Medline is available in the
Additional file 1.
We screened the returned titles and abstracts with the
pre-specified criteria using a liberal-accelerated approach
[29] i.e., a first independent reviewer screened all cita-
tions and a second independent reviewer screened all ti-
tles and abstracts excluded by the first. From citations
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(264 titles) was isolated for a pilot of the full-text screen-
ing and data abstraction approaches. Two independent
reviewers applied the pre-specified criteria to these, re-
solving discrepancies using consensus and involving a
third-party arbiter when necessary. Data abstraction was
completed for 56 eligible articles from the pilot, allowing
for assessment of the process and ascertainment of the
extent to which saturation of outcomes and measures
had been achieved (see Additional file 1). This pilot
work also informed the identification of domains, which
were broad categories describing groups of outcomes,
supported by a leading source in health measurement
[30] and corroborated against the domains described by
the Patient Reported Outcomes Measurement Informa-
tion System Pediatric Self- and Proxy-Reported Health
Framework [13]. Following the pilot, we applied the same
screening and data abstraction strategy to the remaining
citations. Data on study characteristics, patient- and
family-oriented outcomes, and their self-administered
measures were abstracted for all included articles using a
standardized form.
We developed an evolving glossary of outcomes to
guide their categorization. Outcome measures were ab-
stracted as reported by study authors i.e., interpretation
regarding naming conventions used by authors was
withheld. To support these efforts at mitigating bias,
data abstraction for all included studies was carried out
by one independent researcher and verified by a second.
Data were tallied and summarized descriptively.
Because the data were drawn from published literature,
the study was not subject to ethics review. And while we
conducted a scoping review rather than a systematic re-
view, the Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) statement [31] was
used to inform preparation of this report.Results
Search and Screening
Of 4,118 original citations identified, a total of 304 eli-
gible articles were eligible for inclusion as follows
(Figure 1):
Of the 1,322 citations reviewed using full-text, 1,018
were excluded; more than one-third of these (34%)
were abstracts and/or non-peer reviewed sources. An-
other large proportion (20%) described the use of
interviewer- and/or clinician-administered outcome mea-
sures. A third, considerable proportion (15%) did not re-
port on the use of measures specifically within a pediatric
population. Of the 1,322 citations screened at the full-text
phase, 55 (4%) required arbitration regarding inclusion,
mainly due to lack of clarity in reporting the variables of
interest.Report characteristics
Of the 304 included articles, eight major categories of
disease(s) were identified: cerebral palsy, cystic fibrosis,
diabetes, Down syndrome, epilepsy, hemoglobinopathies,
other chronic, and relatively rare [32] pediatric diseases
(hereafter referred to as ‘other diseases’), and reports of
multiple diseases that were eligible for our review. Re-
ports of studies examining diabetes were most common,
accounting for one-third (33%) of those included. Arti-
cles describing studies of cerebral palsy and epilepsy also
comprised substantial proportions of those included
(17% and 15% respectively) (Figure 1). Only three re-
ports from the category of ‘other diseases’ focused spe-
cifically on children with IEM (two reports examining
children with phenylketonuria and one report examining
children with maternally inherited mitochondrial disor-
ders and autosomal recessive metabolic disorders) (see
Additional file 1). The numbers of children meeting our
review’s eligibility criteria were explicitly reported in 283
included reports, with a median number of 76 children
(range 6 to 2,101). Studies of diabetes reported the lar-
gest median number of children (i.e., 84), while studies
of ‘other diseases’ reported the fewest (i.e., 41).
The primary unit of analysis was the child in 43% of
304 included articles; dyadic (caregiver and child) in 28%
of reports; the caregiver in 23% of reports; the entire
family in 4% of reports, and; a sibling in 1% of reports
(Table 2).
Patient- and family-oriented outcomes
Across the 304 included articles, we identified 43 unique
patient- and family-oriented outcomes within five emer-
gent ‘domains’ or broad categories: general health status
and quality of life (3 outcomes); physical health and func-
tional status (11 outcomes); social health and relationships
(10 outcomes); mental health (10 outcomes), and; disease
management and perceptions (9 outcomes) (Additional
file 2). The most commonly measured outcomes were
child general health status and quality of life (143 reports,
47%), child mental health (98 reports, 32%), and family
function and quality of family life (94 reports, 31%). On
the other hand, caregiver cognitive function and the child’s
perceived effect of an intervention were reported as hav-
ing been measured by just one study each.
When reporting on outcomes by disease (Additional
file 2), we re-organized the data for 32 articles that in-
corporated ‘multiple eligible diseases’ i.e., each eligible
disease reported in these articles was placed into its re-
spective single-disease category so that each of these 32
articles simultaneously contributed to multiple disease
categories (Figure 1). The only disease category for
which this resulted in a substantial increase was Down
syndrome, almost tripling the total number of included
articles reporting on this disease from nine to 26.
Figure 1 PRISMA diagram for scoping review of patient- & family-oriented outcomes, measures for chronic, pediatric disease.
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We identified 405 independent measures with variable
frequency of use across domains, diseases, and outcomes.
For readability, we report the top-three most-frequently
reported measures for each of the top-ten most
frequently-reported outcomes (for those measures appear-
ing in at least 3 articles) (Additional file 1). A complete list
of measures by disease and outcome construct is available
in an interactive searchable spreadsheet with full refer-
ences (Additional file 1). Of the top-ten most-frequently-
reported outcomes, six were within the domain of mental
health (Additional file 3) while none were from the do-
main of physical health and functional status. Broad con-
structs such as child general health status and quality of
life were measured using a greater number of unique mea-
sures (i.e., 74), while more narrow constructs such as child
externalizing mental illness were measured using fewer
unique measures (i.e., 14) (Additional file 3).
Among the top-ten most-frequently reported out-
comes, 28 unique measures were identified (Additionalfile 3). Dominant measures sometimes emerged for par-
ticular outcomes e.g., child externalizing mental illness
was reported as having been measured using the Child
Behavior Checklist (CBCL) in 31/49 articles reporting
on this outcome (63%). Conversely, measures used for
other outcomes were more diverse; for example, there
were six measures used most frequently for caregiver
mental health status, but each one appeared in only
three or four of the 64 articles describing this outcome.
Concerning respondents, more than half (54%) of the
28 most-frequently reported measures were reported as
offering multiple versions tailored to self-administered
response from either caregivers or children (Additional
file 3). All but one of the remaining 13 measures were
specific to the caregiver (i.e., measures for which child
self-report was not relevant).
Discussion
Our review sought patient- and family-oriented out-
comes and their self-administered measures as reported
Table 2 Report characteristics
Disease category # reports Median # eligible children
studied (range)*
Primary unit of analysis (#) (% reports) by disease(s)
Cerebral palsy 51 82.5 (6 - 813) Child/adolescent (26) (50%)
Caregiver/parent (9) (18%)
Dyad - child/caregiver (12) (24%)
Family (4) (8%)
Cystic fibrosis 11 42 (23 - 136) Child/adolescent (4) (36%)
Caregiver/parent (4) (36%)
Dyad - child/caregiver (3) (27%)
Diabetes 100 84 (10 - 2,101) Child/adolescent (44) (44%)
Caregiver/parent (18) (18%)
Dyad - child/caregiver (35) (35%)
Sibling (1) (1%)
Family (2) (2%)
Down syndrome 9 42.5 (25 - 440) Child/adolescent (1) (11%)
Caregiver/parent (4) (44%)
Dyad - child/caregiver (2) (22%)
Family (2) (22%)
Epilepsy 47 79.5 (9 - 474) Child/adolescent (26) (55%)
Caregiver/parent (7) (15%)
Dyad - child/caregiver (11) (23%)
Sibling (1) (2%)
Family (2) (4%)
Hemoglobinopathies 25 59 (7 - 320) Child/adolescent (8) (32%)
Caregiver/parent (5) (20%)
Dyad - child/caregiver (11) (44%)
Sibling (1) (4%)
Other diseases 29 41 (12 - 272) Child/adolescent (15) (52%)
Caregiver/parent (7) (24%)
Dyad - child/caregiver (6) (21%)
Family (1) (3%)
Reports of multiple, eligible diseases 32 66.5 (9 - 327) Child/adolescent (8) (25%)
Caregiver/parent (16) (50%)
Dyad - child/caregiver (6) (19%)
Sibling (1) (3%)
Family (1) (3%)
All diseases 304 76 (6 - 2,101) Child/adolescent (132) (43%)
Caregiver/parent (70) (23%)
Dyad - child/caregiver (86) (28%)
Sibling (4) (1%)
Family (12) (4%)
*Medians and ranges reported on articles for which the number of eligible children was explicitly reported (n = 283) i.e., CP = 50 articles; CF = 10 articles; DM = 94
articles; DS = 8 articles; epilepsy = 44 articles; hemoglobinopathies = 24 articles; other diseases = 27 articles; studies of multiple eligible diseases = 26 articles.
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relevance to IEM and their families. While other reviews
have focused on quality of life in children with chronicillness [33,34], this review is the first to our knowledge
that more broadly addresses patient- and family-oriented
outcomes and their measures.
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search into patient- and family-oriented outcomes is
relatively well-developed in the field of diabetes [35] as
compared with less common diseases such as Down syn-
drome, hemoglobinopathies [36] and IEM. This likely re-
flects a larger field of research for diseases with higher
prevalence. Most of our included reports focused on the
child as the primary unit of analysis, but variation across
diseases was apparent. For example, of the 12 reports in
our review describing the family as the primary unit of
analysis, 4 (33%) were reports of cerebral palsy, with
other disease categories contributing 0-2 reports each
(Table 2). This difference may be due to chance, and
because our search was not exhaustive, it is possible that
there is additional literature incorporating family-oriented
outcomes that was missed by our search strategy. None-
theless our findings appear to corroborate acknowledged
gaps in family-oriented research, supporting suggestions
for further research on this topic [37-39].
The five outcome domains we identified closely paral-
lel those within the PROMIS pediatrics framework [40],
although our review additionally describes a domain we
labelled ‘disease management and perceptions’. It is pos-
sible that this reflects our review’s particular focus on
chronic illness for which patient and family perspectives
regarding the management of ongoing care are particu-
larly relevant. While only one outcome (i.e., caregiver/
child roles in disease management) from this unique do-
main was among the top-ten most frequently reported
outcomes, it is notable that this outcome was most often
measured in reports examining diabetes (42/107 (39%)).
Diabetes-specific measures also dominated those fre-
quently used to measure this outcome, which may reflect
the intensive daily dietary and medical management needs
associated with diabetes. While the dietary management
of some IEM is relatively more complex, patient- and
family-oriented outcomes that have been studied within
the field of diabetes are likely to have some applicability to
IEM and/or other rare diseases where diet modifications
and the importance of metabolic control are relevant.
Of the top 10 most-frequently measured outcomes, six
were identified within the domain of mental health. This
may reflect our focus on patient/family reports and on self-
administered tools in particular, since evidence suggests
that results using self-administered measures of mental
health might be more valid than those relying on clinician
reports [41,42]. However, it could also reflect a tendency of
patient-oriented outcomes research in this field to place
particular emphasis on mental health as compared with
other aspects of the patient and family disease experience
[43,44]. Of note, it is unclear whether this emphasis reflects
the priorities of patients and families themselves.
Many of the 28 most-frequently reported outcome
measures allowed for self-administration by childrenthemselves or by their parents/caregivers, demonstrating
respondent versatility. This is important, as parent proxy-
reporting of patient-oriented outcomes, such as quality of
life, is known to often be discordant with that of children
themselves [45]. It appears that, despite long-standing
debate around the extent to which children are able
to adequately self-report [46], a range of child self-
administered outcome measures are available and used
within studies of chronic, pediatric diseases requiring
ongoing management.
Strengths and limitations
Our inclusive approach to identifying a range of patient-
and family-oriented outcomes and self-administered
measures for children with chronic diseases and their
families has produced a breadth of findings that is repre-
sentative of current use in this field of research. We have
developed an interactive spreadsheet (see Additional
file 1) containing the outcomes and measures that we
identified. This tool has potential value for our research in
the field of IEM and also for pediatric researchers studying
other chronic diseases.
Nonetheless, the scope of this review necessitated
methodological tradeoffs that resulted in some limita-
tions. For instance, because we reasoned that outcomes
and measures would be used repeatedly across studies,
we limited the search to electronic databases. Similarly,
our emphasis on outcomes presented challenges when
developing the electronic database search strategy be-
cause a standardized database lexicon describing out-
comes – in particular patient- and/or family-oriented
outcomes – is lacking. This made the development of an
unbiased, sensitive and specific search strategy particu-
larly difficult. To address this, we relied on the expertise
of the working group to identify outcome keywords, and
that of an information scientist to implement these ac-
cording to the review’s objectives. Given the size and
scope of the literature of interest, however, eligible studies
were certainly missed by our search strategy. Nonetheless,
we deemed this limitation acceptable in accordance with
our objectives, and acknowledge that we have identified a
representative, but not exhaustive, set of articles.
As in other reviews [47], incomplete reporting in our
included articles presented additional challenges. For ex-
ample, the extent to which individual articles described
the results of independent studies was often unclear,
limiting our ability to report the results of our review
with studies as the units of analysis, and rather requiring
articles be the unit of analysis. A lack of clarity in report-
ing also presented challenges for screening and data col-
lection, as it was often not possible to determine
whether outcome measures were self- or interviewer-
administered. This resulted in the need for an adjudica-
tion phase within the screening process and may have
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were not actually self-administered. Finally, while abstract-
ing data, accurate identification of standard outcome mea-
sures was challenging as authors used variable naming
conventions and referenced different citations, making it
difficult to ascertain whether two or more measures were
in fact the same. This manifests as a potential limitation
on our capacity to definitively identify the frequency with
which some measures were reported. These challenges
specific to the quality of research reporting represent one
of many reasons for developing, implementing and en-
couraging the use of reporting guidelines [48] to make
published research more useful for knowledge syntheses
and application [49,50].Conclusion
An improved understanding of outcomes that are of pri-
mary importance to children and families living with
chronic disease requiring ongoing management is critical
to informing and supporting patient- and family-centered
health care. Our scoping review of the research in this area
indicates that currently, there are variable approaches to
measuring patient- and family-oriented outcomes. There
is an emphasis on mental health outcomes in this litera-
ture that may or may not reflect the highest priorities of
patients and families themselves. In addition, the com-
paratively well-developed diabetes literature reports a
broad range of patient- and family-oriented outcomes and
self-administered measures that may be relevant to dis-
eases, such as IEM, that are more rare.
We suggest that there is a need for expanded study
of patient- and family-oriented outcomes within rare,
chronic pediatric disease research communities. Such re-
search could build upon the existing literature by incorp-
orating, adapting and validating outcomes and measures
that have been well-studied in other disease contexts; and
could seek to elucidate additional outcomes that are im-
portant to children and their families.Additional files
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